ResearcherHenry Ford HealthActive in the last 2 years

Aseem Rai Bhatnagar

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0005-5188-3696; OpenAlex author ID A5101807986. Sources: OpenAlex.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2024: 2 papers

Papers 2

Long-Term Follow-Up of Phase I Trial of Oncolytic Adenovirus-Mediated Cytotoxic and Interleukin-12 Gene Therapy for Treatment of Metastatic Pancreatic Cancer. Co-author DOI 10.3390/biomedicines12051065 ↗
Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses. First author DOI 10.3390/ijms25189912 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Shyam Nyati · 2 shared papers, 2024 · strength 0.54
- Paper Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses. DOI 10.3390/ijms25189912 ↗
- Paper Long-Term Follow-Up of Phase I Trial of Oncolytic Adenovirus-Mediated Cytotoxic and Interleukin-12 Gene Therapy for Tre… DOI 10.3390/biomedicines12051065 ↗
Shivani Thoidingjam · 1 shared paper, 2024 · strength 0.28
- Paper Optimizing Pancreatic Cancer Therapy: The Promise of Immune Stimulatory Oncolytic Viruses. DOI 10.3390/ijms25189912 ↗
David Kwon · 1 shared paper, 2024 · strength 0.26
- Paper Long-Term Follow-Up of Phase I Trial of Oncolytic Adenovirus-Mediated Cytotoxic and Interleukin-12 Gene Therapy for Tre… DOI 10.3390/biomedicines12051065 ↗
Gazala Naaz Khan · 1 shared paper, 2024 · strength 0.26
- Paper Long-Term Follow-Up of Phase I Trial of Oncolytic Adenovirus-Mediated Cytotoxic and Interleukin-12 Gene Therapy for Tre… DOI 10.3390/biomedicines12051065 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.